Image Cytometry Assists in Meeting Blood Transfusion Supply Challenges

Image cytometry for cell counting, proliferation, cell cycle, and other assays for whole-well live-cell analysis and cell sample characterization in brightfield and fluorescence.

By |2021-05-20T15:26:40+00:00May 20th, 2021|Categories: Celigo Application News, Latest News|0 Comments

Establishing a High-throughput Screening Platform for NK mediated Cytotoxicity using Image Cytometry

Researchers highlight the need for large-scale screening of cytotoxic cells and their ability to kill target cell lines in both a 2D and 3D fashion.

Taking Advantage of Viral Cytopathic Effects to Aid in the Rapid Screening of Effective Viral Therapies

Virology researchers use CPE effects pathogens elicit on the host to study host-pathogen interactions.

Dissecting the Genetic Code of SARS-CoV-2 with Reverse Genetics

The COVID-19 pandemic has increased SARS-CoV-2 research globally resulting in three publicly available vaccines from Moderna, Pfizer (mRNA-based), and Johnson & Johnson (viral vector-based).

Cold-chain Storage Optimization for Umbilical Cord Human Mesenchymal Stem Cells

Effective long-term cryopreservation of human mesenchymal stem cells is an essential component of regenerative medicine and tissue engineering applications.

Direct CAR NK Therapeutic Targeting for High-Risk Neuroblastoma

Detection of novel CD276-CAR NK-92 mediated cytotoxicity of neuroblastoma tumor spheroids using plate-based image cytometry

High-throughput Imaging Cytometry as a Powerful Tool for Drug Repurposing

Drug repurposing, also known as drug repositioning is a powerful tool for the rapid expansion of available therapy options by identifying new therapeutic uses from pre-existing drugs.

Is Your Lab Using High-throughput Image Cytometry to Expedite Viral Assay Development and Research of SARS-CoV-2?

Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.

Fight Against Coronavirus: Nexcelom China Team Provides Assay Development Support to Scientists

Nexcelom's China team works with scientists in State Key Laboratory of Respiratory Diseases in China, for the screening of antiviral agents against SARS-CoV-2 virus, the cause of COVID-19 (Corona Virus).

Webinar on Demand: Role of Aneuploidy and DNA Damage in the Onset of Human Solid Tumors – Lessons from Mouse Models of Chromosome Losses

Available on demand. During this webinar, Dr. Thomas will share his research in cancer biology related to DNA damage in the onset of solid tumors.

Go to Top